Not applicableUnknownNCT05782985What this trial is testingExpression Pattern of HNRNPH1 and HNRNPK Genes in MPNsWho this might be right forMyeloproliferative Neoplasms (MPNs) Assiut University 52
Early research (Phase 1)Looking for participantsNCT06291987What this trial is testingIvosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene MutationWho this might be right forMyeloproliferative Neoplasms University of Chicago 18
Not applicableNot Yet RecruitingNCT06753279What this trial is testingClinical Significance of Leukocyte Cell Population Data in Patients With Myeloproliferative Neoplasms (MPNs)Who this might be right forMyeloproliferative Neoplasms (MPNs) Assiut University 80
Post-approval studies (Phase 4)Not Yet RecruitingNCT06290765What this trial is testingEfficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia VeraWho this might be right forPolycythemia VeraMyeloproliferative Neoplasm PharmaEssentia 70
Early research (Phase 1)Looking for participantsNCT05423691What this trial is testingLeading in MPNs Beyond Ruxolitinib in Combo With T-RegsWho this might be right forMyelofibrosis Cellenkos, Inc. 24
Not applicableNot Yet RecruitingNCT07349134What this trial is testingWELL-MPN: A Digital Lifestyle App for Patients With MPNsWho this might be right forMyeloproliferative Neoplasms (MPNs) Brigham and Women's Hospital 75
Early research (Phase 1)Active Not RecruitingNCT04603001What this trial is testingStudy of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 MutationsWho this might be right forAcute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)+1 more Eli Lilly and Company 260
Not applicableActive Not RecruitingNCT03618485What this trial is testingRegistry of Patients With MPNs in TaiwanWho this might be right forMyeloproliferative Neoplasms Chang Gung Memorial Hospital 500
Testing effectiveness (Phase 2)Study completedNCT05223920What this trial is testingAn Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005)Who this might be right forThrombocythemia, EssentialPrimary Myelofibrosis Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) 81
Testing effectiveness (Phase 2)Ended earlyNCT02718300What this trial is testingINCB050465 in Combination With Ruxolitinib in Subjects With MyelofibrosisWho this might be right forMPN (Myeloproliferative Neoplasms) Incyte Corporation 74
Not applicableStudy completedNCT04153305What this trial is testingEuropean Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST StudyWho this might be right forMyelofibrosis FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 1,010
Early research (Phase 1)Looking for participantsNCT07469891What this trial is testingPRT12396 in Participants With Select Myeloproliferative NeoplasmsWho this might be right forPolycythemia Vera (PV)Myelofibrosis (MF)Myeloproliferative Neoplasms (MPNs)+3 more Prelude Therapeutics 100
Testing effectiveness (Phase 2)Looking for participantsNCT06661915What this trial is testingStudy of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)Who this might be right forAccelerated Phase Myeloproliferative NeoplasmBlast Phase Myeloproliferative NeoplasmEssential Thrombocythemia+5 more National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT04763928What this trial is testingTrial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combination Including Decitabine and VenetoclaxWho this might be right forAcute Myeloid Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 101
Early research (Phase 1)Looking for participantsNCT03326310What this trial is testingSelumetinib and Azacitidine in High Risk Chronic Blood CancersWho this might be right forChronic Myeloid LeukemiaMyelofibroses University of Chicago 18
Testing effectiveness (Phase 2)Looking for participantsNCT06063486What this trial is testingCurcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative NeoplasmsWho this might be right forClonal Cytopenia of Undetermined SignificanceEssential ThrombocythemiaMyelodysplastic Syndrome+2 more University of Southern California 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05177211What this trial is testingFedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)Who this might be right forMyeloproliferative NeoplasmChronic Neutrophilic LeukemiaMDS H. Lee Moffitt Cancer Center and Research Institute 25
Not applicableStudy completedNCT04605211What this trial is testingA Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase InhibitorsWho this might be right forMyeloproliferative NeoplasmChronic Phase Chronic Myelogenous LeukemiaChronic Myeloid Leukemia University of California, San Francisco 47
Testing effectiveness (Phase 2)Ended earlyNCT04103645What this trial is testingIntra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN PatientsWho this might be right forMyeloproliferative Neoplasm Weill Medical College of Cornell University 2
Not applicableNot Yet RecruitingNCT06647706What this trial is testingPrevalence and Risk Factors of Pulmonary Hypertension in Patients with Myeloproliferative Neoplasms in Assiut University Hospital.Who this might be right forMyeloproliferative Neoplasm Assiut University 100